Sponsored by:

Molecular Imaging: Page 283

CoreLab adds new imaging service
By AuntMinnie.com staff writers
CoreLab Partners has launched a new imaging service targeting the utilization of independent central image review in the detection of early Alzheimer's disease.
December 5, 2012
FDA gives PET drugmakers until 2015 to comply with new rules
By Wayne Forrest
The U.S. Food and Drug Administration this week set a December 12, 2015, deadline for PET drug manufacturers to operate under an approved new drug application (NDA), abbreviated new drug application (ANDA), or investigational new drug (IND) submission to continue to make their products.
December 5, 2012
NRG postpones HFR reactor restart
By AuntMinnie.com staff writers
Radiopharmaceutical producer Nuclear Research and Consultancy Group (NRG) on November 30 announced that it has postponed the restart of its High Flux Reactor (HFR) in Petten, the Netherlands, after it discovered an abnormality in the cooling water system of the reactor.
December 5, 2012
Nordion may be on hook to pay AECL
By AuntMinnie.com staff writers
Nordion may have to pay some of Atomic Energy of Canada's (AECL) costs from a 3-year-old dispute related to the ill-fated Multipurpose Applied Physics Lattice Experiment (MAPLE) nuclear reactor project.
December 5, 2012
SNMMI to offer education content at midwinter meeting
By AuntMinnie.com staff writers
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) plans to offer physicians, pharmacists, and physicists up to 36.75 continuing education credits at its midwinter meeting in New Orleans, as well as up to 36.5 hours of Verification of Involvement in Continuing Education (VOICE) credits for nuclear medicine technologists.
December 4, 2012
Increased CT use may boost breast cancer risk
By Kate Madden Yee
Increased use of CT may boost breast cancer risk in certain women, such as younger patients and those who receive repeat exams, according to research presented at the RSNA 2012 meeting. Nuclear medicine exams may also raise the risk of breast cancer.
December 4, 2012
Dilon highlights RSNA MBI research
By AuntMinnie.com staff writers
Breast-specific gamma imaging (BSGI) provider Dilon Diagnostics is highlighting research presented at the RSNA 2012 show that suggests molecular breast imaging (MBI) with the company's BSGI technology can detect breast cancer missed by mammography.
December 3, 2012
Numa adopts virtual model for software
By AuntMinnie.com staff writers
Nuclear medicine connectivity developer Numa has adopted a virtual model for its connectivity and image management software.
December 3, 2012
JNM: FLT-PET aids prognosis of glioma patients
By AuntMinnie.com staff writers
PET imaging with F-18 fluorothymidine (FLT) can noninvasively and accurately provide tumor-specific details to guide the management of patients with gliomas, according to two studies in the December issue of the Journal of Nuclear Medicine.
December 2, 2012
C-11 methionine PET aids diagnosis of adenomas, multiple myeloma
By Wayne Forrest
The radiotracer carbon-11 (C-11) methionine (MET) with PET/CT can help clarify negative or inconclusive FDG-PET findings in multiple myeloma patients, as well as differentiate between atypical and typical pituitary adenomas, according to two Japanese studies presented at last week's RSNA 2012 conference.
December 2, 2012
Mirada gets XD3 install at Johns Hopkins
By AuntMinnie.com staff writers
Medical imaging software developer Mirada Medical has been selected by Johns Hopkins University to provide its XD3 advanced image review and analysis software.
November 28, 2012
Gamma Medica debuts LumaGuide biopsy device at RSNA
By AuntMinnie.com staff writers
Gamma Medica has added the LumaGuide breast biopsy package to its LumaGem molecular breast imaging (MBI) system, and is showing it as a work-in-progress at the 2012 RSNA meeting in Chicago.
November 27, 2012
Previous Page
Page 283 of 615
Next Page